The Subject Expert Committee (SEC) has asked CDSCO to submit data of the reported serious adverse event (SAE), a single death, from the clinical trials of the drug combination of Favipiravir + Umifenovir by Glenmark Pharmaceuticals.
New Delhi: Indian Institute of Chemical Technology (IICT), Hyderabad, is collaborating with Hyderabad-based integrated pharmaceutical company, LAXAI Life Sciences, for synthesis of drugs being used in the fight against the Corona Virus. The collaboration will primarily focus on Umifenovir, Remdesivir and a key intermediate of Hydroxychloroquine (HCQ).
Can old drugs take down a new coronavirus?